Please login to the form below

Not currently logged in
Email:
Password:

disease management

This page shows the latest disease management news and features for those working in and with pharma, biotech and healthcare.

Homesick

Homesick

The cataclysmic manifestation of the problem may lie in the effects that we see with respect to chronic disease management. ... This tsunami of chronic disease management patients who are missing regular and routine  care, the reticence to rebook

Latest news

  • Key emerging trends in digital health Key emerging trends in digital health

    With the potential to ease the demand on overstretched healthcare systems across the world, while simultaneously offering patients the opportunity to control their own disease management, digital health offers an opportunity ... Other chronic conditions,

  • QiC Dermatology is now open for entry QiC Dermatology is now open for entry

    The journal publishes a broad array of articles covering all aspects of skin disease, including – but not limited to – therapeutic developments, clinical articles; from diagnosis to management, practical guides and case ... involved in the diagnosis,

  • Pharma’s race to digital Pharma’s race to digital

    The mobile health market is expanding rapidly and digital therapeutics (DTX) could one day rival mainstream pharmaceuticals in areas such as chronic disease management. ... Already there are examples of digital solutions that allow earlier diagnosis,

  • The end of pharma The end of pharma

    They will develop, provide and maintain disease management systems that incorporate pharmaceuticals but also diagnostic and delivery devices and, probably, patient-flow management systems.

  • The business case for patient engagement The business case for patient engagement

    Over three days in spring 2019, we ran a short, ten-question questionnaire (Patients’ attitudes towards NOACs) for nearly 850 anticoagulation patients using MyTherapy, our medication and disease management app.

More from news
Approximately 4 fully matching, plus 176 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 58 partially matching documents found.

Latest appointments

  • BMS appoints new commercial leader, Davies joins Eisai and more BMS appoints new commercial leader, Davies joins Eisai and more

    The field of genomic medicine has the potential to revolutionise our approach to rare genetic disease diagnosis and management, as well as in other areas of personalised medicine.”. ... Atkins said: “Britten joins our Senior Management team at a

  • Hugh Cole joins Jounce Therapeutics as chief business officer Hugh Cole joins Jounce Therapeutics as chief business officer

    Cole brings over 25 years’ experience in biotech including business development, corporate strategy, R&D, alliance management, commercial planning and execution and corporate leadership. ... He has also held roles for Oscient Pharmaceuticals, The

  • Glyconics appoints CEO Glyconics appoints CEO

    Dr Kam Pooni joins the UK diagnostics firm. UK disease management diagnostics firm Glyconics has appointed Dr Kam Pooni as chief executive officer with immediate effect.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

  • Rare Disease Day – why it’s important to show your stripes Rare Disease Day – why it’s important to show your stripes

    Despite this, most rare diseases still lack approved treatments, with disease management frequently focused on symptomatic relief. ... disease drug development and commercialisation process in any way is both humbling and motivating.

  • ROAD ROAD

    Media relations. Social media. Digital innovation and management. Influencer mapping and engagement. ... Strategic ommunications planning. Message workshops and development. Corporate reputation management. Disease awareness.

  • Our latest additions Our latest additions

    She has worked across a range of therapeutic areas including oncology, inflammation and rare diseases and also has experience in disease awareness, patient advocacy and behavioural change in large pharma. ... Her other focuses include disease awareness,

  • White paper: The impact of COVID-19 on chronic disease management

    Therapy Watch, Research Partnership's syndicated PRF tracker, has been investigating the impact of COVID-19 on chronic disease management.

  • Understanding COVID-19 and varying responses across the globe

    other countries through the international spread of disease requiring a coordinated international response. ... The combination of information sharing and disease management across countries gives us the best chance of beating the virus and bringing an

More from PMHub
Approximately 0 fully matching, plus 35 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Envision Pharma Group

We are a global leader in the medical affairs space. Our purpose-built software and scientific solutions make us a unique...

Latest intelligence

#DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...

Infographics